Precision Livestock Technologies to Present at 2024 Texas A&M Beef Cattle Short Course
CEO Andrew McKenzie Presenting on “Data-Driven Feeding: Artificial Intelligence and Machine Vision to Improve Cattle Intake” DALLAS, Aug....
top of page
- Jun 4
MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer
THIO’s favorable disease control and overall response rates exceed reported standard-of-care data in third line treatment June 04, 2024...
- May 20
Coya Therapeutics Announces $5 Million Strategic Investment by the Alzheimer’s Drug Discovery Foundation (ADDF)
Funds will help support the development of COYA 302 for the treatment of Frontotemporal Dementia (FTD) COYA 302’s combination therapeutic...
- May 9
NeuroSigma Announces Acceptance into 2024 Cohort of the KidsX Accelerator Program
LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced its acceptance into the 2024 cohort of the KidsX...
- May 7
Hopewell Therapeutics to Present Data Highlighting Novel Tissue Targeting Lipid Nanoparticles at the American Society of Gene and Cell Therapy 27th Annual Meeting
WOBURN, Mass., May 7, 2024 /PRNewswire/ -- Hopewell Therapeutics, a biotechnology company focused on discovering, synthesizing, and...
- May 3
Telix Completes Acquisition of QSAM Biosciences and Its Bone Cancer Targeting Platform
Melbourne (Australia) | 03 May 2024 Telix today announces the completion of the acquisition of QSAM Biosciences, Inc. (U.S. OTC: QSAM)...
- Jan 22
Precision Livestock Technologies Releases AI-Powered, Predictive Cattle Feeding Recommendations
DALLAS, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Precision Livestock Technologies (PLT), a leading provider of software and hardware solutions...
- Jan 18
NeuroSigma Announces FDA Clearance of its Second-Generation Monarch eTNS System for Treating Pediatric ADHD
LOS ANGELES, Jan. 17, 2024 -- NeuroSigma today announced that the U.S. Food and Drug Administration (FDA) cleared use of NeuroSigma’s...
bottom of page